A Anell

Summary

Affiliation: The Swedish Institute for Health Economics
Country: Sweden

Publications

  1. ncbi Health outcome measures used in cost-effectiveness studies: a review of original articles published between 1986 and 1996
    A Anell
    Swedish Institute for Health Economics IHE, Lund, Sweden
    Health Policy 51:87-99. 2000
  2. ncbi Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees
    Anders Anell
    The Swedish Institute for Health Economics, 22002 Lund, Sweden
    Eur J Health Econ 5:28-35. 2004
  3. ncbi Swedish healthcare under pressure
    Anders Anell
    The Swedish Institute for Health Economics IHE, Sweden
    Health Econ 14:S237-54. 2005
  4. ncbi Implementing competition in the pharmacy sector: lessons from Iceland and Norway
    Anders Anell
    Swedish Institute for Health Economics, SE 220 02 Lund, Sweden
    Appl Health Econ Health Policy 1:149-56. 2002
  5. ncbi Deregulating the pharmacy market: the case of Iceland and Norway
    Anders Anell
    The Swedish Institute for Health Economics, IHE, P O Box 2127, S 22002, Lund, Sweden
    Health Policy 75:9-17. 2005
  6. ncbi Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?
    Anders Anell
    Swedish Institute for Health Economics, Lund, Sweden
    Eur J Health Econ 6:274-9. 2005
  7. ncbi [Toxicologic information center's hotline--well-received and cost-effective for the society]
    A Anell
    Institutet för hälso och sjukvårdsekonomi IHE, Lund
    Lakartidningen 98:2926-30. 2001
  8. ncbi International comparison of health care systems using resource profiles
    A Anell
    Swedish Institute for Health Economics, Lund, Sweden
    Bull World Health Organ 78:770-8. 2000
  9. ncbi Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees
    A Anell
    Swedish Institute for Health Economics IHE, Lund, Sweden
    Pharmacoeconomics 17:175-85. 2000
  10. ncbi Patient views on choice and participation in primary health care
    P Rosen
    The Swedish Institute for Health Economics IHE, P O Box 2127, S 220 02 Lund, Sweden
    Health Policy 55:121-8. 2001

Detail Information

Publications17

  1. ncbi Health outcome measures used in cost-effectiveness studies: a review of original articles published between 1986 and 1996
    A Anell
    Swedish Institute for Health Economics IHE, Lund, Sweden
    Health Policy 51:87-99. 2000
    ..Furthermore, studies using QALYs or life-years gained often lack a relevant discussion of society's willingness-to-pay per QALY or life-years gained...
  2. ncbi Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees
    Anders Anell
    The Swedish Institute for Health Economics, 22002 Lund, Sweden
    Eur J Health Econ 5:28-35. 2004
    ..While the use of health economic evidence and the outcome of decision making are similar across committees, there is presently only limited knowledge to what extent prescribing patterns are influenced by decisions...
  3. ncbi Swedish healthcare under pressure
    Anders Anell
    The Swedish Institute for Health Economics IHE, Sweden
    Health Econ 14:S237-54. 2005
    ....
  4. ncbi Implementing competition in the pharmacy sector: lessons from Iceland and Norway
    Anders Anell
    Swedish Institute for Health Economics, SE 220 02 Lund, Sweden
    Appl Health Econ Health Policy 1:149-56. 2002
    ..Experiences in both Iceland and Norway highlight the complexity of reforms that fundamentally influence competitive behaviour...
  5. ncbi Deregulating the pharmacy market: the case of Iceland and Norway
    Anders Anell
    The Swedish Institute for Health Economics, IHE, P O Box 2127, S 22002, Lund, Sweden
    Health Policy 75:9-17. 2005
    ..Experiences in both Iceland and Norway highlight the complexity of managing reforms that fundamentally influence competitive behaviour...
  6. ncbi Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?
    Anders Anell
    Swedish Institute for Health Economics, Lund, Sweden
    Eur J Health Econ 6:274-9. 2005
    ..Coordinated decision making is much needed but may be difficult to implement as the perspective, expertise, and objectives of the two public authorities differ...
  7. ncbi [Toxicologic information center's hotline--well-received and cost-effective for the society]
    A Anell
    Institutet för hälso och sjukvårdsekonomi IHE, Lund
    Lakartidningen 98:2926-30. 2001
    ..Improved outcomes, time savings for individual households, and reduced uncertainty for both households and health care staff provide additional benefits...
  8. ncbi International comparison of health care systems using resource profiles
    A Anell
    Swedish Institute for Health Economics, Lund, Sweden
    Bull World Health Organ 78:770-8. 2000
    ..Comparisons based on measures of both real resources and expenditures can be more useful than conventional comparisons of expenditures alone and can lead to important insights for the future management of health care systems...
  9. ncbi Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees
    A Anell
    Swedish Institute for Health Economics IHE, Lund, Sweden
    Pharmacoeconomics 17:175-85. 2000
    ....
  10. ncbi Patient views on choice and participation in primary health care
    P Rosen
    The Swedish Institute for Health Economics IHE, P O Box 2127, S 220 02 Lund, Sweden
    Health Policy 55:121-8. 2001
    ....
  11. ncbi Population preferences and choice of primary care models: a discrete choice experiment in Sweden
    Jonas Hjelmgren
    The Swedish Institute for Health Economics IHE, P O Box 2127, SE 220 02 Lund, Sweden
    Health Policy 83:314-22. 2007
    ..In particular, we studied whether individuals that were given a choice preferred individual family physicians (GP) or a primary care team consisting of physicians and nurses (PCT)...
  12. ncbi The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness
    Sandra Jansson
    IHE, The Swedish Institute for Health Economics, Box 2127, SE 220 02 Lund, Sweden
    Health Policy 76:299-311. 2006
    ..Parallel interventions are needed to meet the objective of cost-effective prescribing...
  13. ncbi [Primary health care--preserve conflicts or patient-centered care?]
    Anders Anell
    Institutet för hälso och sjukvårdsekonomi IHE, Lund
    Lakartidningen 101:1310-2, 1315. 2004
  14. ncbi [Health economic evaluation of recommended drug treatment]
    Stefan Jendteg
    , Lund
    Lakartidningen 99:3130-1. 2002
  15. ncbi [Difficult standpoints to be taken by the committee of costs and subsidies]
    Ulf Persson
    , Lund
    Lakartidningen 99:3128-9. 2002
  16. ncbi [Care Choice on its way in primary health care. Big differences between the models and high needs for development]
    Anders Anell
    , , Lunds universitet
    Lakartidningen 105:2007-10. 2008
  17. ncbi [SBU: society's costs of illness not sufficient as basis for prioritization]
    Ingemar Eckerlund
    Lakartidningen 104:3563-4; author reply 3564. 2007